Is the PTV Margin Important for Local Control in Stage I Non-Small Cell Lung Cancer (NSCLC) Patients Treated With Definitive SBRT?

被引：0
|
作者：
Shaverdian, N. [1 ]
Wang, J. [1 ]
Veruttipong, D. [1 ]
Hegde, J. V. [1 ]
Lee, C. [1 ]
Tenn, S. E. [1 ]
Lee, P. [1 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2015年 / 93卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2015.07.1668
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3097
引用
收藏
页码：E440 / E440
页数：1
相关论文
共 50 条
  • [1] Do Pretreatment Immune Profiles Predict for Tumor Control, Survival and Toxicity in Stage I Non-Small Cell Lung Cancer (NSCLC) Patients Treated With SBRT?
    Shaverdian, N.
    Veruttipong, D.
    Wang, J.
    Schaue, D.
    Kupelian, P. A.
    Lee, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E396 - E396
  • [2] Selection of patients for stereotactic lung radiotherapy (SBRT) for early stage non-small cell lung cancer (NSCLC)
    Pearson, S.
    Franks, K.
    Pearson, S.
    Purdie, T.
    Bissonnette, JI-P.
    Cho, J.
    Sun, A.
    Kane, G.
    Payne, D.
    Bezjak, A.
    RADIOTHERAPY AND ONCOLOGY, 2006, 80 : S51 - S52
  • [3] Anemia is a poor prognostic factor for stage I non-small cell lung cancer (NSCLC) patients treated with Stereotactic Body Radiation Therapy (SBRT)
    Pathak, Rima S.
    Pantarotto, Jason R.
    Cook, Graham
    Holmes, Oliver
    Cross, Peter
    MacRae, Robert M.
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2019, 16 : 28 - 33
  • [4] Stereotactic body radiotherapy (SBRT) for elderly patients with early stage non-small cell lung cancer (NSCLC)
    Mitsuyoshi, T.
    Kawaguchi, Y.
    Konishi, K.
    Teshima, T.
    Nishiyama, K.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S809 - S809
  • [5] Adjuvant Chemotherapy Following SBRT for Early Stage Non-Small Cell Lung Cancer (NSCLC) in Older Patients
    Ganti, A. K.
    Appiah, A. Kusi
    Ernani, V.
    Zhang, C.
    Zhen, W.
    Marr, A.
    Smith, L.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S255 - S255
  • [6] Adjuvant chemotherapy following SBRT for early stage non-small cell lung cancer (NSCLC) in older patients
    Grinnell, Madison
    Appiah, Adams Kusi
    Baine, Michael
    Ernani, Vinicius
    Marr, Alissa
    Zhang, Chi
    Zhen, Weining
    Buddharaju, Laxmi Narayana R.
    Smith, Lynette M.
    Ganti, Apar Kishor
    JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (07) : 1145 - 1153
  • [7] SBRT for Stage 1 Non-Small Cell Lung Cancer
    Eriguchi, Takahisa
    Takeda, Atsuya
    Kimura, Yuto
    Sanuki, Naoko
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (04): : 1088 - 1089
  • [8] Hypofractionated stereotactic body radiotherapy (SBRT) for medically unresectable stage I non-small cell lung cancer (NSCLC)
    Nambiar, A. P.
    Ajlouni, M.
    Jin, J.
    Ryu, S.
    Kim, J. H.
    Movsas, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S484 - S484
  • [9] Definitive thoracic radiotherapy in oligometastatic stage IV non-small cell lung cancer (NSCLC).
    Fernandes, Annemarie Therese
    Xanthopoulos, Eric
    Handorf, Elizabeth
    Grover, Surbhi
    Sharma, Sonam
    Eaby-Sandy, Beth
    Evans, Tracey L.
    Stevenson, James
    Langer, Corey J.
    Mitra, Nandita
    Apisarnthanarax, Smith
    Lin, Lilie
    Rengan, Ramesh
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [10] Influence of PTV underdosage on local control in patients with central NSCLC treated with SBRT
    Duijm, M.
    Van der Voort van Zyp, N.
    Granton, P.
    Van de Vaart, P.
    Mast, M.
    Oomen-de Hoop, E.
    Hoogeman, M.
    Nuyttens, J.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S536 - S536
12345